Shi Z R, Tacha D, Itzkowitz S H
Zymed Laboratories, South San Francisco, California 94080.
J Histochem Cytochem. 1994 Sep;42(9):1215-9. doi: 10.1177/42.9.7520463.
We used a monoclonal antibody, MAb COL-1, which recognized a restricted epitope on the carcinoembryonic antigen (CEA) molecule, to stain a wide variety of human normal and cancerous tissues. None of the 35 different types of normal tissue stained with COL-1. Of 59 types of benign and malignant tissues, COL-1 reacted with neoplasms of epithelial origin, especially the gastrointestinal tract, breast, lung, and bladder. In benign adenomatous colon polyps, villous adenomas were more frequently stained than tubular adenomas. Normal colon tissue from individuals without colon disease was unreactive, but very weak reactivity was noted in normal-appearing mucosa several centimeters remote from colon cancers. In contrast, another anti-CEA antibody with a less restricted epitope reacted frequently with both normal and remote colon mucosa. These results indicate that MAb COL-1 recognizes a restricted CEA epitope expressed only on pre-malignant or malignant cells and therefore may be a useful reagent for immunopathology.
我们使用了一种单克隆抗体MAb COL-1,它识别癌胚抗原(CEA)分子上的一个受限表位,来对多种人类正常组织和癌组织进行染色。35种不同类型的正常组织均未被COL-1染色。在59种良性和恶性组织中,COL-1与上皮来源的肿瘤发生反应,尤其是胃肠道、乳腺、肺和膀胱的肿瘤。在良性结肠腺瘤性息肉中,绒毛状腺瘤比管状腺瘤更常被染色。无结肠疾病个体的正常结肠组织无反应,但在距结肠癌几厘米处外观正常的黏膜中观察到非常微弱的反应。相比之下,另一种表位受限较小的抗CEA抗体则经常与正常和远处的结肠黏膜发生反应。这些结果表明,MAb COL-1识别仅在癌前或恶性细胞上表达的受限CEA表位,因此可能是免疫病理学的一种有用试剂。